Trials / Unknown
UnknownNCT05791838
Experience in Borderline Ovarian Tumors
Borderline Ovarian Tumors: Results of a Retrospective, Single-center Experience
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (estimated)
- Sponsor
- University of Palermo · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study aimed to report the 8-year experience of a single center on the management and outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients with BOTs undergoing surgical treatment were included. Demographic, clinical, and pathological data were reviewed retrospectively.
Conditions
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2023-03-30
- Last updated
- 2023-03-30
Source: ClinicalTrials.gov record NCT05791838. Inclusion in this directory is not an endorsement.